Premium
Prevention of human papillomavirus‐related malignancy: Access is the answer
Author(s) -
Duska Linda R.,
Stoler Mark H.
Publication year - 2013
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.28180
Subject(s) - medicine , cervix , human papillomavirus , cervical cancer , malignancy , cancer , vaccination , race (biology) , disease , socioeconomic status , gynecology , oncology , immunology , population , environmental health , botany , biology
The majority of HPV‐related cancers are caused by HPV 16 and HPV 18, but the distribution of these two viral types vary depending on race and socioeconomic status as well as the particular cancer type (cervix versus other). Ultimately, access to preventative care, including widespread pap smear screening for cervical cancer precursors and HPV vaccination, is the answer to eradicating HPV‐related disease.